Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Temozolomide (Temodal) in Children Over 1 Year of Age With Relapsed or Refractory High Risk Neuroblastoma

NCT00276679 is registered in ClinicalTrials.gov with Children's Cancer and Leukaemia Group as lead sponsor.

NCT NCT00276679
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00276679 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Temozolomide (Temodal) in Children Over 1 Year of Age With Relapsed or Refractory High Risk Neuroblastoma
Lead sponsor
Children's Cancer and Leukaemia Group
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2003
Completion date
November 30, 2006
Enrollment
Not reported
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

neuroblastoma